177 related articles for article (PubMed ID: 19582894)
21. Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells.
Walker UA; Venhoff N; Koch EC; Olschewski M; Schneider J; Setzer B
Antivir Ther; 2003 Oct; 8(5):463-70. PubMed ID: 14640394
[TBL] [Abstract][Full Text] [Related]
22. Upregulatory mechanisms compensate for mitochondrial DNA depletion in asymptomatic individuals receiving stavudine plus didanosine.
Miró O; López S; Rodríguez de la Concepción M; Martínez E; Pedrol E; Garrabou G; Giralt M; Cardellach F; Gatell JM; Vilarroya F; Casademont J
J Acquir Immune Defic Syndr; 2004 Dec; 37(5):1550-5. PubMed ID: 15577406
[TBL] [Abstract][Full Text] [Related]
23. Possible role of mtDNA depletion and respiratory chain defects in aristolochic acid I-induced acute nephrotoxicity.
Jiang Z; Bao Q; Sun L; Huang X; Wang T; Zhang S; Li H; Zhang L
Toxicol Appl Pharmacol; 2013 Jan; 266(2):198-203. PubMed ID: 22820421
[TBL] [Abstract][Full Text] [Related]
24. Subcellular renal proximal tubular mitochondrial toxicity with tenofovir treatment.
Kohler JJ; Hosseini SH
Methods Mol Biol; 2011; 755():267-77. PubMed ID: 21761311
[TBL] [Abstract][Full Text] [Related]
25. Tenofovir alafenamide nephrotoxicity in an HIV-positive patient: A case report.
Novick TK; Choi MJ; Rosenberg AZ; McMahon BA; Fine D; Atta MG
Medicine (Baltimore); 2017 Sep; 96(36):e8046. PubMed ID: 28885375
[TBL] [Abstract][Full Text] [Related]
26. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
Fung HB; Stone EA; Piacenti FJ
Clin Ther; 2002 Oct; 24(10):1515-48. PubMed ID: 12462284
[TBL] [Abstract][Full Text] [Related]
27. Rapid improvement in fasting lipids and hepatic toxicity after switching from didanosine/lamivudine to tenofovir/emtricitabine in patients with toxicity attributable to didanosine.
Palacios R; Rivero A; Santos I; Ríos MJ; Castaño M; del Arco A; Santos González J;
HIV Clin Trials; 2010; 11(2):118-20. PubMed ID: 20542848
[No Abstract] [Full Text] [Related]
28. [Acute renal failure and proximal renal tubular dysfuntion in a patient with acquired immunodeficiency syndrome treated with tenofovir].
de la Prada FJ; Prados AM; Tugores A; Uriol M; Saus C; Morey A
Nefrologia; 2006; 26(5):626-30. PubMed ID: 17117909
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes.
Setzer B; Schlesier M; Thomas AK; Walker UA
Antivir Ther; 2005; 10(2):327-34. PubMed ID: 15865227
[TBL] [Abstract][Full Text] [Related]
30. Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors.
Balcarek K; Venhoff N; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Venhoff AC; Lebrecht D; Walker UA
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):550-7. PubMed ID: 20827217
[TBL] [Abstract][Full Text] [Related]
31. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
[TBL] [Abstract][Full Text] [Related]
32. The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Tenofovir toxicity.
Agarwala R; Mohan S; Herlitz LC; Cheng JT
Kidney Int; 2010 Mar; 77(5):475-6. PubMed ID: 20150949
[No Abstract] [Full Text] [Related]
33. Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.
Negredo E; Garrabou G; Puig J; Lòpez S; Morén C; Bellido R; Ayen R; Cardellach F; Miró O; Clotet B
Antivir Ther; 2008; 13(2):231-40. PubMed ID: 18505174
[TBL] [Abstract][Full Text] [Related]
34. Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine.
Kearney BP; Sayre JR; Flaherty JF; Chen SS; Kaul S; Cheng AK
J Clin Pharmacol; 2005 Dec; 45(12):1360-7. PubMed ID: 16291710
[TBL] [Abstract][Full Text] [Related]
35. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.
Kearney BP; Flaherty JF; Shah J
Clin Pharmacokinet; 2004; 43(9):595-612. PubMed ID: 15217303
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates.
Palmer S; Shafer RW; Merigan TC
Antimicrob Agents Chemother; 1999 Aug; 43(8):2046-50. PubMed ID: 10428934
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients.
Maggiolo F; Roat E; Pinti M; Nasi M; Gibellini L; De Biasi S; Airoldi M; Ravasio V; Mussini C; Suter F; Cossarizza A
Antivir Ther; 2010; 15(1):51-9. PubMed ID: 20167991
[TBL] [Abstract][Full Text] [Related]
38. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells.
Benbrik E; Chariot P; Bonavaud S; Ammi-Saïd M; Frisdal E; Rey C; Gherardi R; Barlovatz-Meimon G
J Neurol Sci; 1997 Jul; 149(1):19-25. PubMed ID: 9168161
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of mitochondrial toxicity induced by zidovudine and adefovir dipivoxil in rats].
Zhu B; Zhu ZN; Wang JZ; Huang SM; Feng XM; Li AY; Yang DL; Wang BJ
Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):794-7. PubMed ID: 23207344
[TBL] [Abstract][Full Text] [Related]
40. Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity.
Zhao X; Sun K; Lan Z; Song W; Cheng L; Chi W; Chen J; Huo Y; Xu L; Liu X; Deng H; Siegenthaler JA; Chen L
Sci Rep; 2017 Apr; 7():46344. PubMed ID: 28397817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
